Honolulu, May 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded the FOCUS 2 study investigating RAP-219, an investigational modulator of AMPA receptors, for adult patients with focal seizures. RAP-219 is a first-in-class, selective negative…
Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating JZP926 or Epidiolex for the treatment of Juvenile Myoclonic Epilepsy (JME). JME is the most common generalized epilepsy syndrome. Myoclonic jerks…
The team at Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit. Honolulu, June 2026 — The Hawaii Comprehensive Epilepsy Center & Epilepsy Research Unit has been awarded a study investigating BMB-101 for the treatment of Developmental and Epileptic Encephalopathies (DEEs).…
Recognition & Excellence Hawaii Pacific Neuroscience Physicians Named 2026 Castle Connolly Top Doctors Four specialists at Hawaii Pacific Neuroscience — along with the center itself — have earned a place among the nation’s most recognized physicians and practices, with Castle…
Epilepsy Research · Hawaii Pacific Neuroscience · Published 2026 Epilepsy Research, Volume 225, 2026 · Hawaii Pacific Neuroscience A new study published in Epilepsy Research by researchers at Hawaii Pacific Neuroscience reveals that Native Hawaiian and Pacific Islander (NHPI) patients…
Epilepsy Research · Hawaii Comprehensive Epilepsy Center Hawaii Awarded Study to Investigate Novel Anti-Galectin-3 Monoclonal Antibody for Drug-Resistant Epilepsy Honolulu, Hawaii · May 2026 · Hawaii Epilepsy Research Unit Dr. Darren Dugas, MD — Neurologist & Epilepsy Specialist, featured on…
Concussion, a form of mild traumatic brain injury (mTBI), is commonly caused by direct or indirect trauma to the head and can lead to temporary neurological dysfunction. While awareness of concussion has increased in recent years, understanding of the condition…
A two-year international study highlights the potential benefits of vagus nerve stimulation (VNS) therapy for individuals living with Lennox–Gastaut syndrome (LGS), a rare and severe form of childhood epilepsy. The findings demonstrate that long-term VNS therapy can reduce seizure frequency,…
A peer-reviewed study published in Epilepsia (October 2025) evaluated the pharmacokinetics, safety, and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy. The findings support appropriate dose selection for adolescents aged 12–17 years, contributing important evidence toward the clinical development…
The American Academy of Neurology (AAN) official continuing medical education journal, Continuum: Lifelong Learning in Neurology®, has referenced research conducted by University of Hawaiʻi John A. Burns School of Medicine (JABSOM) neurologists and former medical students in its February 2025…
RECENT BLOGS
-
WarNight Hacking Forum | 2026 BEST hacking forums
-
UH Professor & Hawaii Neurologist Joins ISTAART Council
-
HPN & Advanced Brain Monitoring Present EEG Biomarker Study at AAIC 2026
-
RAP-219 FOCUS 2 Focal Seizure Study | Hawaii Epilepsy
-
JZP926 & Epidiolex JME Study | Hawaii Epilepsy Center
-
BMB-101 Epilepsy Study (DEEs) | Hawaii Epilepsy Research
-
Hawaii Neurologists: Give Back to Students & Get a Free 2027 HNS Membership Renewal
-
Dr. Natalia Gonzalez Caldito Named Chief of Staff at Hawaiʻi Pacific Neuroscience
HPN Office Hours
Monday :
8AM - 5PM
Tuesday :
8AM - 5PM
Wednesday :
8AM - 5PM
Thursday :
8AM - 5PM
Friday :
8AM - 5PM
Saturday :
CLOSED
SUNDAY :
CLOSED